These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27573688)

  • 21. Chromatin Profiling Techniques: Exploring the Chromatin Environment and Its Contributions to Complex Traits.
    Chawla A; Nagy C; Turecki G
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.
    Nativio R; Donahue G; Berson A; Lan Y; Amlie-Wolf A; Tuzer F; Toledo JB; Gosai SJ; Gregory BD; Torres C; Trojanowski JQ; Wang LS; Johnson FB; Bonini NM; Berger SL
    Nat Neurosci; 2018 Apr; 21(4):497-505. PubMed ID: 29507413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in Genetics and Epigenetic Alterations in Alzheimer's Disease: A Notion for Therapeutic Treatment.
    Rabaneda-Bueno R; Mena-Montes B; Torres-Castro S; Torres-Carrillo N; Torres-Carrillo NM
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic drugs in Alzheimer's disease.
    Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
    Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of epigenetics in Alzheimer's disease pathogenesis.
    Stoccoro A; Coppedè F
    Neurodegener Dis Manag; 2018 Jun; 8(3):181-193. PubMed ID: 29888987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
    Iraola-Guzmán S; Estivill X; Rabionet R
    Clin Genet; 2011 Jul; 80(1):1-14. PubMed ID: 21542837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.
    Signal B; Pérez Suárez TG; Taberlay PC; Woodhouse A
    Neurobiol Dis; 2023 Oct; 186():106284. PubMed ID: 37683959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide epigenomic profiling for biomarker discovery.
    Dirks RA; Stunnenberg HG; Marks H
    Clin Epigenetics; 2016; 8():122. PubMed ID: 27895806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenome mapping in normal and disease States.
    Maunakea AK; Chepelev I; Zhao K
    Circ Res; 2010 Aug; 107(3):327-39. PubMed ID: 20689072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Smith RG; Hannon E; De Jager PL; Chibnik L; Lott SJ; Condliffe D; Smith AR; Haroutunian V; Troakes C; Al-Sarraj S; Bennett DA; Powell J; Lovestone S; Schalkwyk L; Mill J; Lunnon K
    Alzheimers Dement; 2018 Dec; 14(12):1580-1588. PubMed ID: 29550519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.
    Tosto G; Reitz C
    Mol Cell Probes; 2016 Dec; 30(6):397-403. PubMed ID: 27618776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide methylomic regulation of multiscale gene networks in Alzheimer's disease.
    Wang E; Wang M; Guo L; Fullard JF; Micallef C; Bendl J; Song WM; Ming C; Huang Y; Li Y; Yu K; Peng J; Bennett DA; De Jager PL; Roussos P; Haroutunian V; Zhang B
    Alzheimers Dement; 2023 Aug; 19(8):3472-3495. PubMed ID: 36811307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common and Rare Genetic Variants Associated With Alzheimer's Disease.
    Marei HE; Althani A; Suhonen J; El Zowalaty ME; Albanna MA; Cenciarelli C; Wang T; Caceci T
    J Cell Physiol; 2016 Jul; 231(7):1432-7. PubMed ID: 26496533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk.
    Novikova G; Andrews SJ; Renton AE; Marcora E
    Mol Neurodegener; 2021 Apr; 16(1):27. PubMed ID: 33882988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Alzheimer's disease: From pathogenesis to clinical usage.
    Shao W; Peng D; Wang X
    J Clin Neurosci; 2017 Nov; 45():1-8. PubMed ID: 28869135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons from genome-wide association studies findings in Alzheimer's disease.
    Moraes CF; Lins TC; Carmargos EF; Naves JO; Pereira RW; Nóbrega OT
    Psychogeriatrics; 2012 Mar; 12(1):62-73. PubMed ID: 22416831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Search for risk genes in Alzheimer's disease].
    Karaca I; Wagner H; Ramirez A
    Nervenarzt; 2017 Jul; 88(7):744-750. PubMed ID: 28577227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?
    Iatrou A; Kenis G; Rutten BP; Lunnon K; van den Hove DL
    Cell Mol Life Sci; 2017 Feb; 74(3):509-523. PubMed ID: 27628303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.